• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

VibroSense: Signs a distribution agreement with Fu Kang Healthcare in Singapore

VSD BRegulatory press release18.06.2026 klo 09.47
Download the release

VibroSense Dynamics AB (publ) announces today that a distribution agreement has been signed with Fu Kang Healthcare Supply Pte Ltd, a Singapore-based company specialising in distribution of orthopaedic and rehabilitation products. The agreement grants Fu Kang Healthcare the right to market and sell VibroSense Meter® II in Singapore.

Founded in 2005, Fu Kang Healthcare has grown to become one of Singapore's leading suppliers of orthopaedic appliances and rehabilitation products, serving orthopaedic surgeons, occupational therapists, physiotherapists, podiatrists and nurses. The company holds a Good Distribution Practice for Medical Devices (GDPMS) certification issued by the Health Sciences Authority of Singapore, demonstrating its commitment to maintaining the quality and integrity of medical devices throughout the supply chain, a strong foundation for introducing VibroSense Meter® II to the Singapore market. 

"We are pleased to partner with Fu Kang Healthcare, whose expertise and reach within rehabilitation and orthopaedics aligns well with our ambition to establish VibroSense Meter® II as a standard diagnostic tool in Singapore and the wider region", says Toni Speidel, CEO of VibroSense Dynamics AB.


For more information, please contact:
Toni Speidel, CEO
VibroSense Dynamics AB (publ)
Phone: +46 40 88 026
Email: info@vibrosense.com
Website: www.vibrosense.com

"The new Gold Standard for reliable 
detection of nerve damage"

About VibroSense Dynamics AB (publ)
VibroSense Dynamics AB (publ) develops and sells medical devices and services to facilitate diagnosis of nerve damage in the hands and feet. The method is based on measuring and quantifying the ability to perceive vibrations applied to the skin at multiple frequencies. The company's customers include diabetes clinics, occupational health providers, hospitals, primary care centers, and researchers. 
Our vision that the company's products shall become a standard tool in all neurological examinations, to detect early signs of sensory changes so that patients and healthcare providers can take preventive action to avoid, reduce, or delay the onset of nerve damage in the hands and feet.